Tuberculosis News and Research

Latest Tuberculosis News and Research

Huge Malaria vaccine trial in Malawi

This week the African nation of Malawi became one of the first of the planned three to launch a pilot trial for a novel vaccine against malaria. The news and the efforts were lauded by the World Health Organization (WHO).

24 Apr 2019

Pregnant women with type 1 diabetes are at greater risk of preterm birth

Pregnant women with type 1 diabetes are at increased risk of delivering their baby prematurely. The risk increases as blood sugar levels rise, however women who maintain the recommended levels also risk giving birth prematurely.

23 Apr 2019

Key research takeaways from ECCMID 2019

This article aims to provide a brief overview of the key themes of the 29th ECCMID conference and update readers on current research projects.

From ESCMID 19 Apr 2019

Researchers discover new broad-spectrum antibiotic that contains arsenic

Antibiotic resistance has been called one of the biggest public health threats of our time. There is a pressing need for new and novel antibiotics to combat the rise in antibiotic-resistant bacteria worldwide.

16 Apr 2019

Novel models and strategies for TB detection, elimination, and care

This week, publication of a special issue on tuberculosis begins in PLOS Medicine, advised by guest editors Richard Chaisson of Johns Hopkins University, Claudia Denkinger of the University of Heidelberg, and Mark Hatherill of the South African Tuberculosis Vaccine Institute.

8 Apr 2019

Promising new way to thwart tricky Mtb pathogen

Tuberculosis, an ancient and notoriously difficult disease to treat, has killed millions through the course of human history; and the antibiotics that have been used to fight the disease in recent history are becoming less and less effective.

29 Mar 2019

FDA approves treatment for adults with non-radiographic axial spondyloarthritis

The U.S. Food and Drug Administration today approved Cimzia (certolizumab pegol) injection for treatment of adults with a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis (nr-axSpA), with objective signs of inflammation. This is the first time that the FDA has approved a treatment for nr-axSpA.

28 Mar 2019

Autophagy can help combat Salmonella and other pathogens

Autophagy - the process of recycling cellular material in the body, can help combat Salmonella and other pathogens according to researchers at the School of Life Sciences, University of Warwick who have studied how autophagy can get rid of bacteria, and prevent diseases developing.

27 Mar 2019

Improved TB Diagnostic Assay for Better Multiplexing from Bruker

In time for the World Tuberculosis (TB) Day 2019 on Sunday, March 24th, Bruker today announced the launch of an important further innovation in the field of tuberculosis diagnostics.

From Bruker BioSpin - NMR, EPR and Imaging 26 Mar 2019

Aspirin could be used to treat patients with severe tuberculosis infection

Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems.

26 Mar 2019

Shaping new treatments for tuberculosis

To commemorate World TB Day, a Special Collection has been released by PLOS Medicine containing a series of articles that articulate the essential new steps in clinical research that will pave the way for the development of tomorrow's optimal treatment for all forms of tuberculosis.

25 Mar 2019

QIAGEN highlights its global commitment to preventive screening, treatment for latent TB infection

QIAGEN N.V. recognized the annual World TB Day 2019 held on March 24 by highlighting its growing global commitment to preventive screening and treatment for latent tuberculosis (TB) infection, a widespread condition that can lead to active TB disease in vulnerable patients.

25 Mar 2019

Special Collection tracks development of new diagnostic tests for tuberculosis

The Cochrane Infectious Diseases Group (link is external) (CIDG), which has its editorial base at LSTM, helps prepare systematic reviews related to the diagnosis and treatment of tuberculosis.

25 Mar 2019

Anti-TB drugs can increase susceptibility to Mtb reinfection

Current treatments for tuberculosis are very effective in controlling TB infection caused by Mycobacterium tuberculosis. They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.

22 Mar 2019

New survey indicates need of attention to neglected tropical diseases

Although neglected diseases account for 11% of the global disease burden, they are targeted by only a small proportion of the new drugs developed every year.

22 Mar 2019

Many individuals recovering from addiction continue to suffer from chronic physical disease

Alcohol and other substance-use problems take enormous psychological and societal tolls on millions of Americans.

22 Mar 2019

ECDC-WHO report: TB remains a major public health challenge in the European region

The latest ECDC-WHO report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) shows that despite an overall decline in numbers of people suffering from TB, the disease remains a major public health challenge in the Region.

20 Mar 2019

TGen and ABL sign agreement to distribute new TB test technology

n an important step toward eradicating tuberculosis, the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced Biological Laboratories, to market and distribute TGen's patented Next Generation Sequencing-based TB test technology.

19 Mar 2019

Concurrent cuts undermine administration budget proposal

The White House budget proposal for 2020 recommends increases to the domestic HIV programs at the U.S. Centers for Disease Control and Prevention, the Health Resources and Services Administration and Indian Health Services that will be essential to keeping the administration's promise of ending our nation's HIV epidemic in the next decade.

13 Mar 2019

Zinc could help develop new non-antibiotic treatment for bacterial diseases

New details about the role of zinc in our immune system could help the development of new non-antibiotic treatment strategies for bacterial diseases, such as urinary tract infections.

9 Mar 2019